Combined Phaco-Canaloplasty Outperforms Phaco Alone In Eyes With OAG

Wednesday, July 9, 2014

Comments

Ocular Surgery News

Canaloplasty combined with phacoemulsification reduced medication use and IOP more than phacoemulsification alone in patients with open-angle glaucoma, according to study findings.

Full Abstract

All of the following drugs are FDA approved for the treatment of predominantly classic subfoveal CNV in patients with neovascular AMD except for which one?
1. Pegaptanib sodium (Macugen)
2. Verteporfin (Visudyne PDT)
3. Ranibizumab (Lucentis)
4. Bevacizumab (Avastin)
5. All of the above
Check The Answer

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse
CIRRUS HD-OCT 5000 is configured with ... view product
VISUPLAN 500 Non-Contact Tonometer
The measurement of intraocular pressure ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Combined Phaco-Canaloplasty Outperforms Phaco Alone In Eyes With OAG

Comments

Quick Quiz

All of the following drugs are FDA approved for the treatment of predominantly classic subfoveal CNV in patients with neovascular AMD except for which one?

AdGlare RMR Ad

Featured Products

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse

VISUPLAN 500 Non-Contact Tonometer

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us